Bioanalysis Zone is part of Taylor & Francis Group.

  • Taylor & Francis
  • About us
  • Our journals
  • Our Digital Hubs

Taylor & Francis Group is a trading division of Informa that operates through various Informa legal entities including, but not limited to, Informa UK Limited, with the registered address at 5 Howick Place, London, SW1P 1WG, UK.

Taylor & Francis
logo
 
  • Home
  • Awards
  • Events
  • Features
    • An author's perspective
    • Ask the Experts
    • Conference reports
    • eBooks
    • Expert opinion
    • In the Zone
    • Journal articles
    • Journal content
    • Spotlights
    • Tech Digest

    Follow us on social media

  • Glossary
  • Topics
    • Applications
      • Advanced therapies
      • Biomarkers
      • Clinical
      • Diagnostics
      • Drug development
      • Forensics
      • Patient-centric sampling
      • Sports drug testing
      • Toxicology
      • Vaccines
    • Industry updates & regulations
      • Biopharmaceuticals
      • Collaborations & mergers
      • Data processing and interpretation
      • Regulated bioanalysis
    • Molecules
      • Antibodies | ADCs
      • Biosimilars
      • Large molecules
      • Metabolites
      • Oligonucleotides
      • Small molecules
    • Techniques
      • Automation
      • Chromatography
      • Imaging
      • LBA
      • Microsampling
      • MS (LC–MS/MS, HRMS, IMS)
      • Sample preparation

    Follow us on social media

  • Multimedia
    • Coffee chats
    • Infographics
    • Interviews
    • Panel discussions
    • Podcasts
    • Videos
    • Webinars

    Follow us on social media

  • News
  • Partners
  • Register
[WEBINAR] A masterclass in advanced analytical assays for bioanalysis of oligonucleotides 5 days 0 hours 49 mins 7 secs REGISTER NOW!

Spotlight survey on antibody-drug conjugates

14 Apr 2015
General interest

As part of our Spotlight on antibody-drug conjugates (ADCs), Bioanalysis Zone carried out a survey to investigate the techniques used to study ADCs, the issues surrounding their analysis, as well as what the future may hold.

The results can be seen via our infographic. We will also be analyzing the results of the survey during our Spotlight panel discussion, which you can register for here.

 

Top content

  • Novel microchip system mEM speeds up antibody analysis
  • Healthcare, finance and smart materials experts deliver opening and closing plenaries at PharmSci 360
  • eBook: Celebrating 50 years of ion chromatography

Related tags

ADCs
Previous article

Related articles

8 SEP 2015 DRUG DEVELOPMENT
Antibody–drug conjugates nonclinical support: from early to late nonclinical bioanalysis using ligand-binding assays
3 OCT 2013 GENERAL INTEREST
Watch the AB SCIEX Pharma & Biologics Webinar Series from August 21-December 4, 2013
3 SEP 2015 DRUG DEVELOPMENT
Integration of bioanalytical measurements using PK–PD modeling and simulation: implications for antibody–drug conjugate development
13 APR 2015 GENERAL INTEREST
Video: Announcing SWATH™ Acquisition 2.0 (SCIEX)
29 OCT 2019 GENERAL INTEREST
Antibody–drug conjugate drug-to-antibody ratio analysis in serum using IA-LC-HRMS
30 JAN 2014 GENERAL INTEREST
Hot topics in antibody-drug conjugate development
  • About
  • Advertising & Sponsorship
  • Learn
    • Awareness
    • Education zone
    • Professional development
  • Contact Us
  • Permissions
  • Products
  • Zone Leaders
  • Whitelist Emails
  • Accessibility

Contact

Contact Us

Office info

Bioanalysis Zone is powered by Taylor & Francis Group

Bioanalysis Zone, 2-4 Park Square, Milton Park, Abingdon, Oxfordshire, OX14 4RN, United Kingdom
  • Taylor & Francis Group
  • Cookie Policy
  • Privacy Policy
  • Terms & Conditions
  • © 2025 Bioanalysis Zone